All Articles by Author:

Bob

HGF Endogenously Produced by Pancreatic Pericytes Regulates β Cell Function

[Diabetes] Scientists combined human islet single-cell transcriptomics with mouse pancreatic-cell profiling to show that pericytes, rather than endothelial cells, are the primary source of hepatocyte growth factor (HGF) in healthy islets.

Pancreas-Specific Lipid Nanoparticle-Mediated Interleukin-10 mRNA Delivery Ameliorates Acute Pancreatitis

[Journal of Materials Chemistry B] The authors reported the development of a sulfonium lipid nanoparticle system for pancreas-specific interleukin-10 mRNA delivery in acute pancreatitis.

SPINK1-COL18A1 Crosstalk Shapes Epigenome and Drives Cancer Stemness in Pancreatic Ductal Adenocarcinoma

[Cell Reports] Researchers uncovered serine protease inhibitor Kazal type 1 (SPINK1) as a putative determinant of PDAC progression with a previously unrecognized role in epigenomic regulation.

Targeting Addiction to HMGB2-Driven Transcriptional Programs in Pancreatic Cancer

[Cell Reports] Scientists combined single-cell and spatial genomics with patient-derived organoids and tumor samples to show how increased high mobility group-box protein 2 (HMGB2) availability represents a transcriptional addiction that fuels cell-cycle progression and growth.

Loss of PBRM1 Accelerates Pancreatic Cancer Progression by Inducing Acquisition of Mesenchymal Phenotype and Inflammatory Cancer-Associated Fibroblasts Reprogramming

[Cancer Letters] Investigators explored the role of Pbrm1 in tumorigenesis and progression of PDAC by using genetically engineered mouse models.

Dual-Oxygen Pancreatic Cancer Organoids Recapitulate Basal-Classical Heterogeneity Validated by Spatial Transcriptomics

[British Journal of Cancer] Researchers showed that dual-oxygen pancreatic cancer organoids better capture basal–classical tumor heterogeneity, with hypoxia preserving aggressive basal-like cell states found in patient tumors.

Popular

MicrobiotiX Completes Sentinel Cohort of its First-in-Human Clinical Trial of MP101 for Pneumonia

[MicrobiotiX (BioSpace)] MicrobiotiX announced the successful completion of the sentinel cohort of its first-in-human Phase I clinical trial evaluating MP101 in patients with pneumonia caused by Pseudomonas aeruginosa.

Will the mRNA Flu Shot Work Better Than a Regular Seasonal One? What the Science Says

[Nature] The US FDA granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults aged 65 and older.

Methicillin-Resistant Staphylococcus aureus

[Nature Reviews Disease Primers] The spectrum of diseases caused by Methicillin-resistant Staphylococcus aureus range from uncomplicated skin and soft-tissue infections to life-threatening invasive infections such as bacteraemia, pneumonia, osteomyelitis and endocarditis.